Dr Jameson Voss, MD | |
300 Twining St Bldg 760, Maxwell Afb, AL 36112-6027 | |
(334) 953-3368 | |
Not Available |
Full Name | Dr Jameson Voss |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
Location | 300 Twining St Bldg 760, Maxwell Afb, Alabama |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1285955211 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 0101250205 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Jameson Voss, MD 300 Twining St Bldg 760, Maxwell Afb, AL 36112-6027 Ph: (334) 953-3368 | Dr Jameson Voss, MD 300 Twining St Bldg 760, Maxwell Afb, AL 36112-6027 Ph: (334) 953-3368 |
News Archive
Dementia and Alzheimer's disease: issues around working partnership between carers and psychiatrists is the title of the new Partners in Care campaign leaflet.
News outlets examine what's behind the activity during recent town-hall meetings as activists voice concerns about the GOP spending plan, which was advanced by Rep. Paul Ryan, R-Wis. Experts wonder, though, whether the mounting criticism is organic or rooted in Washington political theatrics.
A new study finds that young muskoxen conserve heat almost as well as adults, a finding that runs contrary to a longstanding assumption among scientists that young animals should be more vulnerable in extreme cold. The study, by biologist Adam Munn from the University of Sydney, Australia, will be published in the forthcoming issue of Physiological and Biochemical Zoology.
Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that the 725th event (patient death) has been reached in its pivotal Phase 3 trial in advanced non-small cell lung cancer (NSCLC) studying its lead product, NOV-002, in combination with first-line chemotherapy.
A mutant rat that mimics a 400-pound human is helping scientists understand early vascular changes that make walking a pain for more than 2 million Americans.
› Verified 2 days ago
Dr. David Jacob Simmons, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 300 Twining St Bldg 760, 42 Mdg/sgp, Maxwell Afb, AL 36112 Phone: 334-953-3712 Fax: 334-953-8296 |